Viewing Study NCT02244502


Ignite Creation Date: 2025-12-25 @ 4:04 AM
Ignite Modification Date: 2026-01-12 @ 11:55 AM
Study NCT ID: NCT02244502
Status: UNKNOWN
Last Update Posted: 2016-09-21
First Post: 2014-09-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Feasibility and Effect of TTFields (200 kHz) Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma (INNOVATE)
Sponsor: NovoCure Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module